Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

LYNCH BIOLOGICS, LLC

US

Last updated May 24, 2026

What LYNCH BIOLOGICS, LLC makes

Lynch BioLogics, LLC produces periodontal root surface regeneration materials designed to promote tissue growth and healing in dental procedures. Their portfolio includes products like GEM 21S® and the GEM 21S Growth Factor Enhance Matrix, which are applied in regenerative therapies for periodontal treatment.

These devices are classified as Class III under FDA regulations, requiring Premarket Approval (PMA) and are listed in the FDA’s Unique Device Identifier (UDI) database. The company is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Lynch BioLogics, LLC manufacture?

Lynch BioLogics, LLC specializes in periodontal root surface regeneration materials. These devices are specifically designed to aid in tissue regeneration and healing during dental procedures, such as periodontal treatments. Their primary focus is on products that promote bone and tissue growth in the oral cavity.

Where is Lynch BioLogics, LLC based?

Lynch BioLogics, LLC is headquartered in the United States. The company’s location is relevant for understanding regulatory oversight, as it operates under the jurisdiction of the U.S. Food and Drug Administration (FDA).

Which regulatory registries or databases list Lynch BioLogics, LLC’s devices?

Lynch BioLogics, LLC’s devices are listed in the FDA’s Premarket Approval (PMA) registry and the FDA’s Unique Device Identifier (UDI) database. These registries ensure traceability and compliance tracking for Class III devices, which require rigorous pre-market authorization.

How are Lynch BioLogics, LLC’s devices classified under FDA regulations?

Lynch BioLogics, LLC’s devices fall under Class III classification by the FDA. This classification applies to products that support or sustain life, are of substantial importance in preventing impairment of human health, or present a potential unreasonable risk of illness or injury. Class III devices require Premarket Approval (PMA) due to their higher risk profile.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
079604282

Catalogue (23)

DeviceModel / ReferenceRegistriesClassStatus
GEM™ Bone Graft LBNB4010
FDA UDI
Class IIUnknown
GEM™ Bone Graft LBNB1020
FDA UDI
Class IIUnknown
GEM™ Bone Graft LBNB1010
FDA UDI
Class IIUnknown
GEM™ Synthetic Bone Graft LBSB050
FDA UDI
Class IIUnknown
GEM™ Bone Graft LBNB2020
FDA UDI
Class IIUnknown
GEM™ Wound Dressing Foam LBWDF
FDA UDI
UUnknown
Gem 21s® LBGEM05
FDA UDI
Class IIIActive
GEM Adapt™ LBADAPT3040
FDA UDI
Class IIUnknown
GEM™ Wound Dressing Plug LBWDP
FDA UDI
UUnknown
GEM™ Synthetic Bone Graft LBSB100
FDA UDI
Class IIUnknown
GEM Extend™ LBEXT1520
FDA UDI
Class IIUnknown
GEM Adapt™ LBADAPT1520
FDA UDI
Class IIUnknown
GEM™ Wound Dressing Tape LBWDT
FDA UDI
UUnknown
GEM™ Synthetic Bone Graft LBSB200
FDA UDI
Class IIUnknown
GEM Extend™ LBEXT2030
FDA UDI
Class IIUnknown
GEM™ Bone Graft LBNBS025
FDA UDI
Class IIUnknown
GEM™ Bone Graft LBNBS05
FDA UDI
Class IIUnknown
GEM™ Bone Graft LBNB2010
FDA UDI
Class IIUnknown
GEM™ Bone Graft LBNB0510
FDA UDI
Class IIUnknown
GEM Adapt™ LBADAPT2030
FDA UDI
Class IIUnknown
GEM Cap™ LBCAP1216
FDA UDI
Class IIUnknown
GEM Extend™ LBEXT3040
FDA UDI
Class IIUnknown
Gem 21s Growth Factor Enhance Matrix P040013
FDA PMA
Class IIIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.